Asymmetry Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-166,099
| Closed | -$2.2M | – | 32 |
|
|
2016
Q4 | $2.2M | Buy |
166,099
+1,943
| +1% | +$25.7K | 4.09% | 12 |
|
|
2016
Q3 | $3.89M | Buy |
164,156
+93,921
| +134% | +$2.23M | 6.76% | 6 |
|
|
2016
Q2 | $2.02M | Buy |
70,235
+8,185
| +13% | +$236K | 3.71% | 13 |
|
|
2016
Q1 | $1.99M | Buy |
62,050
+10,620
| +21% | +$340K | 5.18% | 9 |
|
|
2015
Q4 | $2.2M | Buy |
51,430
+13,151
| +34% | +$562K | 3.33% | 12 |
|
|
2015
Q3 | $1.35M | Buy |
+38,279
| New | +$1.35M | 3% | 16 |
|